+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Non-ionic Iodine Contrast Media Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129168
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Non-ionic Iodine Contrast Media Market is projected to reach USD 5.33 Billion in 2026. It is expected to continue growing at a CAGR of 4.75%, reaching USD 7.03 Billion by 2032.

Non-Ionic Iodine Contrast Media: Executive Overview

Non-ionic iodine contrast media are radiographic agents used to improve visualization during computed tomography, angiography, fluoroscopy, and other X-ray-based examinations. Their clinical value is linked to image enhancement, diagnostic confidence, and suitability for a broad range of procedures. Adoption is shaped by patient safety considerations, imaging capacity, procurement standards, regulatory requirements, and the availability of trained clinical personnel.

Safety, Workflow, and Imaging Innovation Are Reshaping Use

The landscape is being transformed by greater attention to adverse-event prevention, renal-risk assessment, allergy documentation, dose optimization, and standardized administration protocols. Hospitals are also emphasizing efficient imaging workflows, automated injectors, protocol consistency, and supply resilience. Advances in CT hardware and reconstruction methods are encouraging more precise use of contrast while supporting efforts to reduce unnecessary exposure and improve examination quality.

Artificial Intelligence Strengthens Protocol Selection and Quality Control

Artificial intelligence is increasingly relevant to contrast-enhanced imaging through automated protocol recommendations, patient-risk stratification, scan-quality assessment, and workflow prioritization. AI-supported reconstruction and image analysis may help clinicians obtain diagnostically useful examinations with more efficient contrast administration. Effective deployment still depends on representative clinical data, interoperability, validation across scanners and patient groups, cybersecurity, and clear human oversight.

Regional Insights: Infrastructure and Access Define Adoption Patterns

North America is characterized by advanced imaging infrastructure, structured clinical protocols, and strong attention to safety and reimbursement. Latin America is shaped by uneven access to equipment, import dependence, and concentration of specialized services in major urban centers. Europe combines mature hospital systems with stringent quality, environmental, and regulatory expectations. The Middle East is expanding specialized diagnostic capacity while managing workforce and procurement requirements. Africa presents substantial differences between urban referral facilities and underserved areas, making affordability, logistics, and training central concerns. Asia-Pacific spans highly developed imaging systems alongside rapidly expanding and resource-constrained settings, creating varied requirements for procurement, localization, and clinical education.

Group Insights: Trade, Regulation, and Health-System Coordination Matter

ASEAN markets differ in infrastructure, reimbursement, and regulatory maturity, but share opportunities to strengthen procurement coordination, training, and distribution. BRICS members reflect varied public-private health systems and domestic manufacturing capabilities, with access and supply resilience remaining important themes. The European Union emphasizes harmonized regulatory compliance, patient safety, sustainability, and cross-border health-system standards. G7 countries generally combine sophisticated imaging services with rigorous evidence, quality, and pharmacovigilance expectations. GCC members are investing in advanced healthcare capacity while relying on coordinated procurement and specialized expertise. NATO members represent diverse national systems, yet interoperability, emergency preparedness, and resilient medical supply chains are relevant common priorities.

Country Insights: Diverse Clinical and Regulatory Priorities

Australia emphasizes centralized quality standards, rural access, and efficient use of specialist imaging services. Brazil faces geographic disparities and a mixed public-private delivery structure. Canada must balance advanced diagnostic capacity with regional access and public-system resource management. China is expanding imaging capability while strengthening domestic healthcare capacity and regulatory oversight. France, Germany, Italy, and Spain operate within European safety and compliance frameworks, with differing procurement and hospital organization. India combines rapidly growing diagnostic demand with major urban-rural variation and price sensitivity. Japan and South Korea emphasize technologically advanced imaging, aging-population needs, and rigorous clinical practice. Mexico is addressing unequal access and dependence on centralized or imported supply channels. Russia’s environment is influenced by domestic production, logistics, and changing access to international healthcare inputs. The United Kingdom prioritizes public-system efficiency, protocol standardization, and equitable access. The United States combines extensive imaging utilization with strong attention to safety, reimbursement, supply continuity, and clinical governance.

Actions for Leaders: Build Safe, Resilient, and Data-Enabled Delivery

Industry leaders should align product strategy with evidence-based safety protocols, renal and hypersensitivity risk management, and clear administration guidance. They should strengthen multi-source procurement and inventory monitoring, while tailoring distribution and training to local infrastructure. Partnerships with imaging providers can support protocol optimization, staff education, and post-market safety surveillance. AI initiatives should begin with clinically defined use cases, validated datasets, transparent performance monitoring, and integration into existing radiology workflows. Sustainability planning should also address packaging, transport, waste handling, and responsible resource use without compromising sterility or patient safety.

Methodology: Evidence-Led Review of Clinical, Regulatory, and Operational Drivers

This executive summary uses a structured qualitative review of the non-ionic iodine contrast media landscape. The assessment organizes insights by clinical application, safety considerations, imaging technology, healthcare infrastructure, regulation, procurement, supply continuity, and geographic context. Regional, group, and country comparisons are framed around documented health-system characteristics and implementation conditions rather than numerical market measures. Interpretations should be validated against current clinical guidelines, regulatory communications, procurement policies, and institution-specific data before operational decisions are made.

Conclusion: Safe Access and Workflow Integration Will Guide Progress

The future direction of non-ionic iodine contrast media will depend on the interaction of diagnostic demand, patient-safety standards, imaging innovation, and reliable supply. Regional disparities mean that successful approaches must be adapted to infrastructure, workforce, reimbursement, and regulatory conditions. Leaders that combine evidence-based administration, resilient procurement, responsible AI adoption, and continuous quality improvement will be better positioned to support consistent diagnostic care across diverse health systems.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Non-ionic Iodine Contrast Media Market, by Type
7.1. Introduction
7.2. Iso Osmolar Contrast Media
7.3. Low Osmolar Contrast Media
8. Non-ionic Iodine Contrast Media Market, by Application
8.1. Introduction
8.2. Cardiovascular Angiography
8.2.1. Cerebral Angiography
8.2.2. Coronary Angiography
8.2.3. Peripheral Angiography
8.3. Computed Tomography
8.3.1. Body Ct
8.3.2. Head Ct
8.4. Urological Procedures
8.4.1. Intravenous Urography
8.4.2. Retrograde Urography
9. Non-ionic Iodine Contrast Media Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Diagnostic Centers
9.3.1. Clinic Based Diagnostic Centers
9.3.2. Standalone Diagnostic Centers
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
10. Non-ionic Iodine Contrast Media Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Non-ionic Iodine Contrast Media Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Non-ionic Iodine Contrast Media Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Bayer AG
14.2. Beijing Beilu Pharmaceutical Co., Ltd.
14.3. Bracco Imaging S.p.A.
14.4. Consentis Diagnostics GmbH
14.5. Daiichi Sankyo Company, Limited
14.6. Fuji Pharmaceutical Co., Ltd.
14.7. FUJIFILM Holdings Corporation
14.8. General Electric Company
14.9. Grupo Juste
14.10. Guerbet Group
14.11. Hengrui Medicine Co., Ltd.
14.12. Hikari Pharmaceutical Co., Ltd.
14.13. Imax Diagnostic Imaging Limited
14.14. Jodas Expoim Pvt. Ltd.
14.15. Lantheus Medical Imaging, Inc.
14.16. Mallinckrodt Pharmaceuticals plc
14.17. Sagent Pharmaceuticals, Inc.
14.18. Sanochemia Pharmazeutika AG
14.19. Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
14.20. Sichuan Kelun Pharmaceutical Co., Ltd.
14.21. T2Pharma
14.22. Taejoon Pharm Co., Ltd.
14.23. Takeda Pharmaceutical Company Limited
14.24. Towaseiyaku Co., Ltd.
14.25. Yangtze River Pharmaceutical Group
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Non-ionic Iodine Contrast Media Market, Years Considered for the Study
FIGURE 2. Global Non-ionic Iodine Contrast Media Market, Research Design
FIGURE 3. Global Non-ionic Iodine Contrast Media Market, Research Framework
FIGURE 4. Global Non-ionic Iodine Contrast Media Market, Data Triangulation
FIGURE 5. Global Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Non-ionic Iodine Contrast Media Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Non-ionic Iodine Contrast Media Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Non-ionic Iodine Contrast Media Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Non-ionic Iodine Contrast Media Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Non-ionic Iodine Contrast Media Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Non-ionic Iodine Contrast Media Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Non-ionic Iodine Contrast Media Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Non-ionic Iodine Contrast Media Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Non-ionic Iodine Contrast Media Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Non-ionic Iodine Contrast Media Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Non-ionic Iodine Contrast Media Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Non-ionic Iodine Contrast Media Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Non-ionic Iodine Contrast Media Market Segmentation & Coverage
TABLE 2. Global Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 3. Global Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Iso Osmolar Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Iso Osmolar Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Iso Osmolar Contrast Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Low Osmolar Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Low Osmolar Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Low Osmolar Contrast Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 11. Global Cardiovascular Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Cardiovascular Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Cardiovascular Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Cerebral Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Cerebral Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Cerebral Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Coronary Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Coronary Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Coronary Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Peripheral Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Peripheral Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Peripheral Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Body Ct Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Body Ct Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Body Ct Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Head Ct Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Head Ct Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Head Ct Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Urological Procedures Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Urological Procedures Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Urological Procedures Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Intravenous Urography Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Intravenous Urography Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Intravenous Urography Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Retrograde Urography Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Retrograde Urography Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Retrograde Urography Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 42. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Clinic Based Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Clinic Based Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Clinic Based Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Standalone Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Standalone Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Standalone Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Non-ionic Iodine Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Non-ionic Iodine Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 73. North America Non-ionic Iodine Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. North America Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 75. North America Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. North America Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 77. North America Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 78. North America Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 79. North America Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. North America Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 81. North America Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 82. Latin America Non-ionic Iodine Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Latin America Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 84. Latin America Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 85. Latin America Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 86. Latin America Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 87. Latin America Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 88. Latin America Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Latin America Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 90. Latin America Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 91. Europe Non-ionic Iodine Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Europe Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 93. Europe Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Europe Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 95. Europe Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 96. Europe Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 97. Europe Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Europe Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 99. Europe Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 100. Middle East Non-ionic Iodine Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Middle East Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 102. Middle East Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Middle East Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 104. Middle East Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 105. Middle East Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 106. Middle East Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Middle East Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 108. Middle East Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 109. Africa Non-ionic Iodine Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Africa Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 111. Africa Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Africa Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 113. Africa Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 114. Africa Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 115. Africa Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Africa Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 117. Africa Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 118. Global Non-ionic Iodine Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. ASEAN Non-ionic Iodine Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. ASEAN Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 121. ASEAN Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. ASEAN Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 123. ASEAN Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 124. ASEAN Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 125. ASEAN Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. ASEAN Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 127. ASEAN Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 128. GCC Non-ionic Iodine Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. GCC Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 130. GCC Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. GCC Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 132. GCC Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 133. GCC Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 134. GCC Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. GCC Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 136. GCC Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 137. European Union Non-ionic Iodine Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. European Union Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 139. European Union Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. European Union Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 141. European Union Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 142. European Union Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 143. European Union Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. European Union Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 145. European Union Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 146. BRICS Non-ionic Iodine Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. BRICS Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 148. BRICS Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. BRICS Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 150. BRICS Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 151. BRICS Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 152. BRICS Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. BRICS Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 154. BRICS Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 155. G7 Non-ionic Iodine Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. G7 Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 157. G7 Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. G7 Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 159. G7 Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 160. G7 Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 161. G7 Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. G7 Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 163. G7 Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 164. NATO Non-ionic Iodine Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. NATO Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 166. NATO Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. NATO Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 168. NATO Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 169. NATO Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 170. NATO Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. NATO Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 172. NATO Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 173. Global Non-ionic Iodine Contrast Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. United States Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 175. United States Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 176. United States Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. United States Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 178. United States Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 179. United States Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 180. United States Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. United States Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 182. United States Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 183. Canada Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 184. Canada Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 185. Canada Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Canada Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 187. Canada Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 188. Canada Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 189. Canada Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Canada Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 191. Canada Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 192. Mexico Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 193. Mexico Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 194. Mexico Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. Mexico Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 196. Mexico Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 197. Mexico Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 198. Mexico Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Mexico Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 200. Mexico Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 201. Brazil Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 202. Brazil Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 203. Brazil Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Brazil Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 205. Brazil Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 206. Brazil Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 207. Brazil Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. Brazil Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 209. Brazil Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 210. United Kingdom Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 211. United Kingdom Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 212. United Kingdom Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. United Kingdom Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 214. United Kingdom Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 215. United Kingdom Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 216. United Kingdom Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. United Kingdom Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 218. United Kingdom Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 219. Germany Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 220. Germany Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 221. Germany Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Germany Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 223. Germany Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 224. Germany Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 225. Germany Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Germany Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 227. Germany Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 228. France Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 229. France Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 230. France Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. France Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 232. France Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 233. France Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 234. France Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. France Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 236. France Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 237. Russia Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 238. Russia Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 239. Russia Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Russia Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 241. Russia Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 242. Russia Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 243. Russia Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. Russia Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 245. Russia Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 246. Italy Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 247. Italy Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 248. Italy Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Italy Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 250. Italy Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 251. Italy Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 252. Italy Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Italy Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 254. Italy Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 255. Spain Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 256. Spain Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 257. Spain Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. Spain Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 259. Spain Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 260. Spain Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 261. Spain Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Spain Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 263. Spain Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 264. China Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 265. China Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 266. China Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. China Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 268. China Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 269. China Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 270. China Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. China Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 272. China Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 273. India Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 274. India Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 275. India Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 276. India Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 277. India Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 278. India Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 279. India Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. India Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 281. India Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 282. Japan Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 283. Japan Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 284. Japan Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. Japan Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 286. Japan Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 287. Japan Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 288. Japan Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Japan Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 290. Japan Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 291. Australia Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 292. Australia Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 293. Australia Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 294. Australia Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 295. Australia Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 296. Australia Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 297. Australia Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 298. Australia Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 299. Australia Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 300. South Korea Non-ionic Iodine Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 301. South Korea Non-ionic Iodine Contrast Media Market Size, by Type, 2017-2032 (USD Million)
TABLE 302. South Korea Non-ionic Iodine Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 303. South Korea Non-ionic Iodine Contrast Media Market Size, by Cardiovascular Angiography, 2017-2032 (USD Million)
TABLE 304. South Korea Non-ionic Iodine Contrast Media Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 305. South Korea Non-ionic Iodine Contrast Media Market Size, by Urological Procedures, 2017-2032 (USD Million)
TABLE 306. South Korea Non-ionic Iodine Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. South Korea Non-ionic Iodine Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 308. South Korea Non-ionic Iodine Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 309. Global Non-ionic Iodine Contrast Media Market Share, by Key Player, 2025
TABLE 310. Global Non-ionic Iodine Contrast Media Market, Key Experts

Companies Mentioned

  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Imaging S.p.A.
  • Consentis Diagnostics GmbH
  • Daiichi Sankyo Company, Limited
  • Fuji Pharmaceutical Co., Ltd.
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • Grupo Juste
  • Guerbet Group
  • Hengrui Medicine Co., Ltd.
  • Hikari Pharmaceutical Co., Ltd.
  • Imax Diagnostic Imaging Limited
  • Jodas Expoim Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt Pharmaceuticals plc
  • Sagent Pharmaceuticals, Inc.
  • Sanochemia Pharmazeutika AG
  • Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • T2Pharma
  • Taejoon Pharm Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Towaseiyaku Co., Ltd.
  • Yangtze River Pharmaceutical Group